PRELUDE THERAPEUTICS INC Finance Lease, Liability
PRELUDE THERAPEUTICS INC (PRLD) had Finance Lease, Liability of $53.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:FinanceLeaseLiability · last filed 2025-05-06
- 2025-03-31: Finance Lease, Liability $53.00K.
- 2024-12-31: Finance Lease, Liability $208.00K.
- 2024-09-30: Finance Lease, Liability $359.00K.
- 2024-06-30: Finance Lease, Liability $507.00K.
| Period end | Finance Lease, Liability |
|---|---|
| 2025-03-31 | $53.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $208.00K 10-K · filed 2025-03-10 |
| 2024-09-30 | $359.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $507.00K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |